​

Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?

OverviewForecastFinancialsChartTranscripts

Neumora Therapeutics Ownership Summary

Neumora Therapeutics is owned by 13.72% institutional investors, 23.93% insiders, and 62.35% retail investors. Siren is the largest institutional shareholder, holding 5.20% of NMRA shares.

NMRA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeumora Therapeutics13.72%23.93%62.35%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Siren8.50M5.20%$16.57M
Softbank group6.09M3.73%$11.88M
Perceptive advisors5.10M3.12%$9.95M
Vanguard group4.54M2.80%$8.13M
Mic capital management uk llp4.46M2.73%$8.70M
Fmr3.50M2.14%$6.82M
Wellcome trust ltd (the) as trustee of the wellcome trust3.31M2.03%$6.45M
Millennium management2.75M1.69%$5.37M
Iconiq capital2.56M1.57%$4.99M
Lunate capital2.12M1.30%$4.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lunate capital2.12M3.44%$4.14M
Mic capital management uk llp4.46M2.47%$8.70M
Johnson & johnson1.85M0.55%$3.61M
Siren8.50M0.46%$16.57M
Ikarian capital1.28M0.20%$2.49M
Perceptive advisors5.10M0.19%$9.95M
Addis & hill163.39K0.19%$318.60K
Silverarc capital management818.16K0.16%$1.60M
Iconiq capital2.56M0.11%$4.99M
Softbank group6.09M0.10%$11.88M

Top Buyers

HolderShares% AssetsChange
Perceptive advisors5.10M0.19%5.10M
Siren8.50M0.46%2.21M
Adage capital partners gp1.00M0.00%1.00M
Silverarc capital management818.16K0.16%818.16K
Tudor investment corp et al771.42K0.00%771.42K

Top Sellers

HolderShares% AssetsChange
Capital investors---3.70M
Point72 asset management602.40K0.00%-3.07M
Ecor1 capital---2.07M
Baker bros. advisors lp---1.03M
Rock springs capital management lp---955.11K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors5.10M0.19%5.10M$9.95M
Adage capital partners gp1.00M0.00%1.00M$1.95M
Silverarc capital management818.16K0.16%818.16K$1.60M
Tudor investment corp et al771.42K0.00%771.42K$1.50M
Vanguard fiduciary trust535.03K0.00%535.03K$1.04M

Sold Out

HolderChange
Gamma investing-16.00
Ifp advisors-32.00
Ronald blue trust-38.00
Lindbrook capital-48.00
Corecap advisors-57.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202649-53.77%22,411,846-64.48%130.90%23-58.18%10-56.52%
Dec 31, 202565-35.00%32,985,290-34.97%202.07%29-12.12%14-65.00%
Sep 30, 202598-4.85%49,889,004-11.08%302.56%32-38.46%3930.00%
Jun 30, 2025100-13.79%56,072,937-7.73%342.45%50-20.63%30-6.25%
Mar 31, 2025116-27.95%65,233,669-16.60%401.68%62-31.11%32-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 17, 2026Aurora Daljit Singh See RemarksSell$21.92K
Feb 17, 2026Pinto Joshua PresidentSell$21.09K
Feb 17, 2026BERNS PAUL L See RemarksSell$34.46K
Feb 17, 2026Milligan Michael Lee See RemarksSell$5.12K
Nov 11, 2025Aurora Daljit Singh See RemarksSell$307.03K

Insider Transactions Trends

DateBuySell
2026 Q1-4
2025 Q431
2025 Q2--
2025 Q1-5
2024 Q4-4

NMRA Ownership FAQ

Who Owns Neumora Therapeutics?

Neumora Therapeutics shareholders are primarily institutional investors at 13.72%, followed by 23.93% insiders and 62.35% retail investors. The average institutional ownership in Neumora Therapeutics's industry, Biotech Stocks , is 34.84%, which Neumora Therapeutics falls below.

Who owns the most shares of Neumora Therapeutics?

Neumora Therapeutics’s largest shareholders are Siren (8.5M shares, 5.20%), Softbank group (6.09M shares, 3.73%), and Perceptive advisors (5.1M shares, 3.12%). Together, they hold 12.05% of Neumora Therapeutics’s total shares outstanding.

Does Blackrock own Neumora Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neumora Therapeutics.

Who is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested?

Lunate capital is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.44% of its assets in 2.12M Neumora Therapeutics shares, valued at 4.14M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools